Literature DB >> 8149989

Evidence that a serotonergic mechanism is involved in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats.

Q S Yan1, P C Jobe, J W Dailey.   

Abstract

Fluoxetine (15 mg/kg i.p.) decreased the audiogenic seizure intensity in 33% of severe seizure genetically epilepsy-prone rats (GEPR-9s). 5-Hydroxytryptophan (5-HTP, 12.5 mg/kg i.p.) produced no anticonvulsant effect in GEPR-9s. When GEPR-9s were treated with a combination of these two drugs, the combination treatment decreased the audiogenic seizure intensity in 83% of the animals tested. Brain microdialysis studies showed that the same combination of 5-HTP and fluoxetine also produced a marked potentiation of the increase in the extracellular serotonin concentration in the thalamus of freely-moving GEPR-9s when compared with administration of either drug alone. A negative correlation between audiogenic seizure intensity and extracellular serotonin concentration existed after either fluoxetine alone or the combination treatment. No significant changes in extracellular norepinephrine concentrations were observed after the combination treatment. These results coupled with our earlier reports strongly suggest that a serotonergic mechanism is involved in the anticonvulsant effects of fluoxetine in GEPRs.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8149989     DOI: 10.1016/0014-2999(94)90581-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  17 in total

1.  Successful treatment of epilepsy with serotonin reuptake inhibitors: proposed mechanism.

Authors:  C Albano; A Cupello; P Mainardi; S Scarrone; E Favale
Journal:  Neurochem Res       Date:  2006-05-13       Impact factor: 3.996

2.  Zimelidine decreases seizure susceptibility in stressed mice.

Authors:  D Pericić; D S Strac; J Vlainić
Journal:  J Neural Transm (Vienna)       Date:  2006-06-01       Impact factor: 3.575

3.  Stimulation of 5-HT1A receptors in the dorsal hippocampus and inhibition of limbic seizures induced by kainic acid in rats.

Authors:  M Gariboldi; P Tutka; R Samanin; A Vezzani
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

4.  Antidepressants but not antipsychotics have antiepileptogenic effects with limited effects on comorbid depressive-like behaviour in the WAG/Rij rat model of absence epilepsy.

Authors:  Rita Citraro; Antonio Leo; Pasquale De Fazio; Giovambattista De Sarro; Emilio Russo
Journal:  Br J Pharmacol       Date:  2015-04-10       Impact factor: 8.739

Review 5.  Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder?

Authors:  L Cardamone; M R Salzberg; T J O'Brien; N C Jones
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

6.  Depression in epilepsy: a neurobiologic perspective.

Authors:  Andres M Kanner
Journal:  Epilepsy Curr       Date:  2005 Jan-Feb       Impact factor: 7.500

7.  Prolonged but not acute fluoxetine administration produces its inhibitory effect on hippocampal seizures in rats.

Authors:  Y Wada; J Shiraishi; M Nakamura; H Hasegawa
Journal:  Psychopharmacology (Berl)       Date:  1995-04       Impact factor: 4.530

Review 8.  From unwitnessed fatality to witnessed rescue: Pharmacologic intervention in sudden unexpected death in epilepsy.

Authors:  George B Richerson; Detlev Boison; Carl L Faingold; Philippe Ryvlin
Journal:  Epilepsia       Date:  2016-01       Impact factor: 5.864

9.  Epileptic seizures but not pseudoseizures are associated with decreased density of the serotonin transporter in blood platelet membranes.

Authors:  Aroldo Cupello; Daniela Audenino; Simona Scarrone; Michele Fornaro; Elena Gatta; Pantaleo Fornaro; Claudio Albano
Journal:  Neurochem Res       Date:  2008-04-22       Impact factor: 3.996

10.  Further evidence of anticonvulsant role for 5-hydroxytryptamine in genetically epilepsy-prone rats.

Authors:  Q S Yan; P C Jobe; J W Dailey
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.